Citi analyst Geoff Meacham reiterated a Buy rating and $150.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Kymera Therapeutics (KYMR) PT Raised to $150 at CitiOctober 5, 2026 5:03 AM Form 4 Kymera Therapeutics, For: Oct 01 Filed by: Mainolfi NelloOctober 1, 2026 5:20 PM Form 144 Kymera Therapeutics, Filed by: Mainolfi NelloOctober 1, 2026 4:10 PM Wells Fargo names 13 stocks as overweight tactical ideasOctober 1, 2026 6:30 AM B.Riley Reiterates Buy Rating on Kymera Therapeutics (KYMR)October 1, 2026 5:06 AM